Submission requirements for Innovations in Clinical Neuroscience (Online ISSN 2158-8341, Print ISSN 2158-8333) are in accordance with the International Committee of Medical Journal Editors (ICMJE). See Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
To submit a manuscript, please access
our online submission platform by clicking HERE.
Innovations in Clinical Neuroscience is a peer-reviewed electronic-only journal (www.innovationscns.com) designed to provide healthcare clinicians and researchers with up-to-date, evidence-based information in a straightforward “how-to” fashion on new or emerging treatment options, drug development trends, theoretical concepts, drug trial methodology, and practice management issues in the field of neuroscience, including psychiatry, neurology, pain, and Alzheimer’s, to improve patient outcomes.
SCOPE OF MANUSCRIPTS
Manuscripts that meet our editorial purpose include but are not limited to: (1) reports of preclinical and clinical research studies that expand existing knowledge in the field of neuroscience; (2) case reports, case series, and case studies that stimulate research and the exchange of information beyond what is currently found in the literature in the field of neuroscience; (3) in-depth reviews that synthesize new or emerging information on treatment options, drug development, drug trial methodology, practice management, reimbursement, education, ethics, and legal issues in the field of neuroscience; (4) reports on contemporary issues in neuroscience that may affect drug or device development, delivery of services, reimbursement, and clinical practice of psychiatry, neurology, or related fields; and (5) commentaries that offer unique, substantiated discussions on theorectical concepts, current or emerging trends in clinical practice (including treatment and diagnosis issues), trial methodology, drug development, regulatory issues, or other topics related to neuroscience that affect patient outcome.
Original Research. Reports of investigations that address questions about clinical care or clinical trial methodology or expand existing knowledge. References and abstract are required. Illustrative material is recommended. Recommended length: up to 6000 words, not including references.
Review Articles. Comprehensive articles that synthesize and summarize the latest research to facilitate the clinician’s approach to diagnosis and treatment and articles highlighting emerging diagnostic and therapeutic modalities. May also include in-depth reviews of clinical practice, pracice management, drug development, trial methodology, reimbursement and educational, ethical, or legal issues. References (at least 25 current references are recommended) and abstract required. Illustrative material is preferred. Recommended length: up to 6000 words, not including references.
Case Series, Studies, or Reports. Short presentations of actual cases that stimulate research and the exchange of information beyond what is currently found in the literature and illustrate the signs and symptoms, diagnosis, and treatment of a disorder. Case presentations should provide unique or new information that is not well-covered in the current literature. References (at least 15 current references are recommended) and abstract required. Illustrative material is preferred. Recommended length 1000 to 3000 words, not including references.
Brief Reports. Short reports of original studies, trial methodology, or case series. Must include abstract. Recommended length: 1000 to 1500 words (not including references).
Commentaries. Essays that address important topics in neuroscience and generally are not linked to a specific article. Commentaries should offer unique perspectives that are well focused, scholarly, and clearly presented. Include approximately 20 references. Recommended length: 1500 to 2000 words.
Letters to the Editor. Opinions on cases or articles published in Innovations in Clinical Neuroscience, opinions on other current topics, or short reports of clinical interest. Must be concise and to the point. Text should not exceed 600 words (not including references), with no more than 10 references. Letters regarding a specific article published in Innovations in Clinical Neuroscience should be received within four months of the article’s publication release and may be sent to the original author for reply. Submission of a letter does not guarantee publication or response. Notify editor if letter is not intended for publication should be The editor reserves the right to edit the material for style, clarity, and size.
Submissions for consideration may be submitted online via Editorial Manager. Emailed submissions no longer accepted.
Corresponding Author. Each manuscript submission should have a designated corresponding author. The corresponding author will be the editor’s single point of contact and will be responsible for communicating any information from the editor regarding the submitted manuscript to the coauthors.
Cover Letter. Manuscripts should be submitted with a cover letter indicating the article type. The cover letter should give details on any previous or duplicate publication of any of the content and should state that the paper is not under consideration for publication elsewhere. In the cover letter, authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript. For Letters to the Editor, please indicate whether the letter is intended for publication.
Conflict of Interest Disclosures. All authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript in the cover letter of the submitted manuscript.
Author and Copyright Forms. Upon submission, corresponding author will receive an acknowledgement email with author and copyright forms attached. It is the responsibility of the corresponding author to distribute the author and copyright forms to all of the coauthors. All authors for each submission are required to complete, sign, and return these forms prior to publication. The corresponding author may not sign on behalf of any coauthor.If the manuscript is accepted and published in Innovations in Clinical Neuroscience, authors must transfer copyright to Matrix Medical Communications.
Registration of Clinical Trials. As recommended by the ICMJE, Innovations in Clinical Neuroscience requires as a condition of consideration for publication registration of all clinical trials in a public trials registry that requires the minimum registration data set as determined by the ICMJE, which can be accessed via http://www.icmje.org/index.html#clin_trials. Please include the trial registry name, registration number, and the url for the registry in the abstract.
Inclusion of Previously Published Materials. Any material submitted to Innovations in Clinical Neuroscience that is reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder UPON?SUBMISSION. All such material should include a full credit line (e.g., in the figure or table legend) acknowledging the original source. The author is responsible for obtaining the permission and is responsible for any associated fees.
Title Page. The title page should contain the following elements: title, author names and institutional affiliations, sources of financial support, name of corresponding author with his or her complete contact information (mailing address, telephone and fax numbers, e-mail address), and word count (text only).
Spacing and Pagination. The manuscript should be typed using double spacing throughout. Do not use a running head. Pages should be numbered beginning with the title page. Manuscripts should NOT contain any automatic formatting, except for the page number at the top right corner of each page.
Abstract. Include a structured abstract with all articles, except letters to the editors. Original research abstracts should be organized using the following categories: Objective, Design, Setting, Participants, Measurements, Results, Conclusion. Abstracts of clinical trials must include trial registry information (registry name, registration number, and url for the registry). Review article, case report, and brief report, abstracts should be organized using the following categories: Objective, Method, Results, Conclusion. Abstracts of commentaries should include the following categories: Objective, Main Points of Discussion, Conclusion.
Keywords. Include all relevant keywords following the abstract.
Abbreviations/Acronyms. All abbreviations and acronyms should be spelled out at first mention.
References. PLEASE NOTE: Manuscripts with incorrectly formatted or incomplete references will be returned to the author and will not be entered into the peer-review process until references are corrected by the author. Citation accuracy is the responsibility of the author. Requirements are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. References must be cited in text in numerical order and must appear as a complete enumerated list at the end of the manuscript. Do not superscript reference numbers in the text; place the numbers at the end of the corresponding sentences or paragraphs between brackets and after ending punctuation. Abbreviate names of journals according to Index Medicus style. Do NOT use punctuation between author(s) first name initials. Specific reference formatting requirements are as follows (please see Uniform Requirements for Manuscripts Submitted to Biomedical Journals for reference types not included below):
Books. The sequence for book references should be author(s) or editor(s) last name followed by first name initial; up to four author/editor names; for five or more authors/editors, list the first three, followed by et al), title of book, edition number, location of publisher, publisher, copyright year, volume, and specific page numbers for quoted material (if applicable). Example:
1. Stahl SM. Stahl’s Essential Psychopharmacology, Fourth Edition. New York, NY: Cambridge University Press;2008:15–23.
The sequence for chapters of a book should be: author(s) last name followed by first name initial; up to four author names; for five or more authors, list the first three, followed by et al), chapter title, editor(s) (last name followed by first name initial; up to four editor names; for five or more editors, list the first three, followed by et al), book title, edition, place of publication, publisher, year, page numbers.
2. Holland JC, Gooen-Piels J. Principles of psycho-oncology. In: Holland JC, Frei E (eds). Cancer Medicine, Fifth Edition. Hamilton (Ontario): Decker;2000:943–958.
Journal articles. The sequence for a journal article should be: author(s) last name followed by first name initial; up to four author names; for five or more authors, list the first three, followed by et al), title of paper, journal name abbreviated as in the Index Medicus, year of publication, volume number, issue number and first and last page numbers. Example:
3. Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20:3137–3148.
Proceedings. The sequence for conference proceedings is author(s) last name followed by first name initial; up to four author names; for five or more authors, list the first three, followed by et al), name of presentation, name of meeting, year month day, location. Example:
4. Heller T. Promoting healthy aging and community inclusion of adults with developmental disabilities. Presented at the National Association for the Dually Diagnosed; 2003 Oct 24; Chicago, Illinois.
Websites. The sequence for website listings is author(s) last name followed by first name initial; up to four author names; for five or more authors, list the first three, followed by et al) or if no author is available, the name of the organization responsible for the site, title of the specific item cited (if none is given, use the name of the organization responsible for the site), name of the website (use “website” not “Web site”), URL (provide URL and verify that the link still works), published date (if available), updated date (if available), accessed date (Tip: Include as much relevant information as possible). Example with author:
5. Rainie L. The rise of the e-patient. Pew Research Center Internet and the American Life Project website. http://www.pewinternet.org/Presentations/2009/40-The-rise-of-the-e-patient.aspx. October 7, 2009. Accessed January 11, 2012.
Example with no author:
6. Air Pollution and Respiratory Health. Centers for Disease Control and Prevention website http://www.cdc.gov/Environmental/. Updated January 9, 2012. Accessed March 2, 2012
Authors are responsible for ensuring that the list contains all references cited in the text, in order, accurately.
Tables and Figures. All illustrative material must be numbered consecutively according to citation in text. If a figure or table has been previously published, the complete reference information must be cited, and written permission from the publisher to reproduce must be submitted with the manuscript prior to peer review. Obtaining permission (and any associated fees) to include previously published materials in a Innovations in Clinical Neuroscience submission is the responsibility of the author. Photographic illustrations may be submitted as color or black-and-white electronic .jpg, .tif, or .pdf files (min. 300 dpi). Any drawings must be professionally executed and submitted electronically. Tables and graphs must be provided in Word or Excel. Symbols and abbreviations should be defined/spelled out. For black-and-white or color photographs, the required resolution is at least 300 dpi. For line drawings, the resolution must be at least 600 dpi.
Peer Review. All submissions undergo a single-blind, peer-review process to ensure that the material is clinically relevant and concise. A minimum of two reviewers will assess each submision. Strict confidentiality regarding the submitted manuscript is maintained. Based on the reviewers/editors’ comments, manuscripts may be accepted, rejected, or recommended for revision. Reviewers’ comments that are considered constructive will be shared with the corresponding author. The editor reserves the right to reject an article at any time, including previously accepted articles or after revisions have been made by the authors. The corresponding author will be notified when an article is accepted or rejected or requires revisions.
Editing and Page Proofs. Articles accepted for publication will be edited for grammar, syntax, and style consistent with journal requirements. Galley proofs will be sent to the corresponding author prior to publication for approval. The corresponding author may be asked to make minor revisions at this stage. The author will be given no more than 48 hours to respond with changes/corrections. The author is responsible for all changes in the manuscript, including those of the copy editor.
Upon publication. The corresponding author of each article receives a PDF of his or her article. The PDF is copyright protected and ?is for the corresponding author’s files only. Corresponding author may email PDF to co-authors and colleagues who request it for research purposes. The PDF may not be mass distributed in any way (including e-mail or print) or posted on any website (including internal sites) without express written permission from the publisher (fees may apply). Electronic and printed reprints are available at a discounted price to the corresponding author. Contact Elizabeth Klumpp for pricing at email@example.com.
Innovations in Clinical Neuroscience is indexed with PubMed Central, PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature®), CINAHL® Plus with Full Text, Scopus, and Embase.
• Original manuscript (double-spaced)
• Cover letter affirming the manuscript’s originality and stating any financial disclosures
• Corresponding author’s name, address, phone number, fax number, and e-mail address on the title page
• References cited in consecutive order in text and conformed to Uniform Requirments style
• Black-and-white or color figures supplied as electronic .jpg or .tif files with a minimum 300dpi
• Professionally executed drawings, algorithms, graphs, charts, etc, with all symbols and abbreviation/ acronyms defined and supplied as electronic .jpg or .tif files with a minimum 300dpi
• Copies of permission letters to reproduce previously published and unpublished material.
Submissions for consideration may be submitted online via Editorial Manager. Emailed submissions no longer accepted.
Contact Elizabeth Klumpp, Executive Editor, MMC, Send Email (Hard copy submissions and emailed submissions are no longer accepted.) Phone: (866) 325-9907 (toll-free), (484) 266-0702, Fax: (484) 266-0726